These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
418 related articles for article (PubMed ID: 28537052)
1. Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles. Mochtar MH; Danhof NA; Ayeleke RO; Van der Veen F; van Wely M Cochrane Database Syst Rev; 2017 May; 5(5):CD005070. PubMed ID: 28537052 [TBL] [Abstract][Full Text] [Related]
2. Gonadotrophins for ovulation induction in women with polycystic ovary syndrome. Weiss NS; Kostova E; Nahuis M; Mol BWJ; van der Veen F; van Wely M Cochrane Database Syst Rev; 2019 Jan; 1(1):CD010290. PubMed ID: 30648738 [TBL] [Abstract][Full Text] [Related]
3. Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles. Youssef MA; Abou-Setta AM; Lam WS Cochrane Database Syst Rev; 2016 Apr; 4(4):CD003719. PubMed ID: 27106604 [TBL] [Abstract][Full Text] [Related]
4. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome. Tso LO; Costello MF; Albuquerque LET; Andriolo RB; Macedo CR Cochrane Database Syst Rev; 2020 Dec; 12(12):CD006105. PubMed ID: 33347618 [TBL] [Abstract][Full Text] [Related]
5. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI). Ngwenya O; Lensen SF; Vail A; Mol BWJ; Broekmans FJ; Wilkinson J Cochrane Database Syst Rev; 2024 Jan; 1(1):CD012693. PubMed ID: 38174816 [TBL] [Abstract][Full Text] [Related]
6. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology. Youssef MA; Van der Veen F; Al-Inany HG; Mochtar MH; Griesinger G; Nagi Mohesen M; Aboulfoutouh I; van Wely M Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD008046. PubMed ID: 25358904 [TBL] [Abstract][Full Text] [Related]
7. Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Mochtar MH; Van der Veen ; Ziech M; van Wely M Cochrane Database Syst Rev; 2007 Apr; (2):CD005070. PubMed ID: 17443569 [TBL] [Abstract][Full Text] [Related]
8. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI). Lensen SF; Wilkinson J; Leijdekkers JA; La Marca A; Mol BWJ; Marjoribanks J; Torrance H; Broekmans FJ Cochrane Database Syst Rev; 2018 Feb; 2(2):CD012693. PubMed ID: 29388198 [TBL] [Abstract][Full Text] [Related]
9. Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation. Kamath MS; Maheshwari A; Bhattacharya S; Lor KY; Gibreel A Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008528. PubMed ID: 29096046 [TBL] [Abstract][Full Text] [Related]
10. Long-acting FSH versus daily FSH for women undergoing assisted reproduction. Pouwer AW; Farquhar C; Kremer JA Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009577. PubMed ID: 26171903 [TBL] [Abstract][Full Text] [Related]